Artidis® AG is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. By combining its nanotechnology platform for rapid tissue analysis with a holistic data solution, Artidis® accelerates drug discovery, tissue engineering, and personalized treatment. Artidis® focuses its research and development efforts on solid tumors to enhance responses to chemotherapy, immunotherapy, and cell therapies, driving precision in cancer care.